Partnering with the global gold standard for high-viability, stability-tested Bifidobacterium infantis probiotics for the nutraceutical and functional food industries.
As the demand for gut-brain axis health spikes, Bifidobacterium infantis has become a premium asset. We leverage China's advanced fermentation technology to provide high-CFU count strains that meet rigorous international stability standards.
By integrating R&D with manufacturing, we mitigate global volatility. Our Xi'an-based facility ensures consistent, year-round production of bulk probiotic powders, bypassing common supply bottlenecks.
We are pioneering micro-encapsulation techniques to ensure B. infantis survives stomach acid, delivering maximum efficacy in final dosages like gummies and shelf-stable capsules.
A: As a "super probiotic," it is essential for infant health and adult gut regulation, requiring specialized handling to ensure potency. Our batch-testing protocols ensure your label claims are met.
A: Yes. We provide full regulatory dossiers, including COA, MSDS, and allergen certificates, tailored for EU, FDA, and Asian market entry requirements.
